Trapidil

曲匹地尔

Report date: 2023/03/21 20:00:39
NME

Base Information

Drug NameTrapidil
Drug Alias NameTrapidilum曲皮地尔Travisco RRocornalAR-12008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Global Approved IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Approved Indications in ChinaMyocardial InfarctionCoronary DiseaseAngina Pectoris
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesWuhan Jiu'An Pharmaceutical Co LtdMochda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsMyocardial InfarctionCoronary DiseaseAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC01DX11
Related LinksWikipediaDrugBankKEGG